HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tournefolic acid B

from Tournefortia sarmentosa (Boraginaceae); structure in first source

Also Known As:

3-(4,7,8-trihydroxydibenzo(b,f)oxepin-1-yl)acrylic acid

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - tournefolic acid B: 2

Experts

1.	Sun, Guibo: 1 article (01/2019)
2.	Sun, Xiaobo: 1 article (01/2019)
3.	Wang, Shan: 1 article (01/2019)
4.	Xing, Na: 1 article (01/2019)
5.	Xu, Xudong: 1 article (01/2019)
6.	Yu, Yingli: 1 article (01/2019)
7.	Zhu, Yindi: 1 article (01/2019)

Related Diseases

1.	Myocardial Ischemia (Ischemic Heart Diseases) 07/04/2023 - "Tournefolic acid B (TAB) was proven to be a potent component against myocardial ischemia reperfusion injury (MIRI) from Clinopodium chinense (Lamiaceae). " 01/01/2019 - "Tournefolic acid B, derived from Clinopodium chinense (Benth.) Kuntze, protects against myocardial ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress-regulated apoptosis via PI3K/AKT pathways."
2.	Reperfusion Injury 07/04/2023 - "Tournefolic acid B (TAB) was proven to be a potent component against myocardial ischemia reperfusion injury (MIRI) from Clinopodium chinense (Lamiaceae). " 01/01/2019 - "Tournefolic acid B, derived from Clinopodium chinense (Benth.) Kuntze, protects against myocardial ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress-regulated apoptosis via PI3K/AKT pathways."